{"id":"NCT01168973","sponsor":"Eli Lilly and Company","briefTitle":"A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy","officialTitle":"A Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung Cancer Following Disease Progression After One Prior Platinum-Based Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-12","primaryCompletion":"2013-12","completion":"2016-08","firstPosted":"2010-07-23","resultsPosted":"2014-12-29","lastUpdate":"2019-09-25"},"enrollment":1253,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Non-Small Cell Lung Cancer"],"interventions":[{"type":"BIOLOGICAL","name":"Ramucirumab","otherNames":["IMC 1121B","LY3009806"]},{"type":"DRUG","name":"Placebo (for Ramucirumab)","otherNames":[]},{"type":"DRUG","name":"Docetaxel","otherNames":[]}],"arms":[{"label":"Ramucirumab + Docetaxel","type":"EXPERIMENTAL"},{"label":"Placebo + Docetaxel","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of the study is to compare the survival of participants who receive chemotherapy and ramucirumab versus chemotherapy alone as second line treatment for NSCLC after prior first line platinum-based chemotherapy.","primaryOutcome":{"measure":"Overall Survival","timeFrame":"Randomization to date of death from any cause (up to 34 months)","effectByArm":[{"arm":"Ramucirumab and Docetaxel","deltaMin":10.5,"sd":null},{"arm":"Placebo and Docetaxel","deltaMin":9.1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":12,"exclusionCount":26},"locations":{"siteCount":231,"countries":["United States","Argentina","Austria","Brazil","Canada","France","Germany","Greece","Hungary","India","Israel","Italy","Mexico","Netherlands","New Zealand","Norway","Poland","Puerto Rico","Romania","Russia","South Korea","Spain","Sweden","Switzerland","Taiwan","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["35930972","31958290","24933332","22853980"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":284,"n":627},"commonTop":["Fatigue","Neutropenia","Diarrhoea","Decreased appetite","Nausea"]}}